Patents
Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175)
06/2003
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003CA2812024A1 Methods for ligand discovery
06/05/2003CA2464094A1 Methods for ligand discovery
05/2003
05/29/2003US20030100613 Substituted imide derivatives
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003CN1420863A Substd. imide derivs.
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311477A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566034 Photographic material containing a novel hydrazine type
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003US20030092046 Monomer for use in huaman therapeutics and diagnostics
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/07/2003CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia
05/01/2003WO2002026701A3 Ionic liquids and their use as solvents
04/2003
04/30/2003CN1107056C Process for preparation of clonidine derivatives
04/29/2003US6555570 Growth hormone secretagogous with improved bioavailability
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/17/2003WO2003031399A1 Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates
04/17/2003WO2000037430A3 Use of androgen receptor suppressors
04/16/2003EP1301467A2 9-substituted minocycline compounds
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/10/2003US20030069307 Oxidation resistance; free radical scavenger; foods, drugs, cosmetics
04/09/2003EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
04/08/2003US6545182 Methods and compositions for modulating alpha adrenergic receptor activity
04/08/2003US6545052 Contacting skin with skin treatment composition having concentration of 1-(3-methoxybenzyl)-3-substituted thiourea compound effective for inhibiting free radical generation
04/03/2003WO2003027064A1 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical co mpositions containing the same
04/03/2003US20030065033 Lipid derivatives of polythiourea
04/02/2003EP1296941A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/2003
03/27/2003WO2003024921A1 Alkyl urea retinoid agonists i
03/27/2003WO2003024920A1 Substituted urea retinoid agonists ii
03/27/2003US20030060662 Passing mixture of Carbon dioxide ad hydrogen sulphide into a slurry formed by addition of calcium cyanamide into water using constant stirring, under alkaline pH, heating; separating thiourea solution, treating solution with activated
03/26/2003EP1295867A1 Biphenyl compound
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/18/2003US6534639 Guanidinium functionalized oligonucleotides and method/synthesis
03/18/2003US6534546 Aniline derivatives possessing an inhibitory effect of nitric oxide synthase
03/18/2003US6534542 For alleviating chronic pain and allodynia and have no or only minimal cardivascular and/or sedatory activity
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/12/2003EP1289940A2 Excitatory amino acid receptor modulators
03/12/2003CN1401636A Process for preparing N,N'-diphenyl sulfourea
03/11/2003US6531495 Potassium channel
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2002068384A3 (2-hydroxy)ethyl-thioureas useful as modulators of alpha2b adrenergic receptors
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/04/2003US6528532 Benzenesulfonamide group
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
02/2003
02/27/2003WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof
02/27/2003WO2002068383A3 Thiol-modified hyaluronan
02/27/2003WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
02/27/2003US20030040483 Compounds with growth hormone releasing properties
02/26/2003EP1285909A1 Process for the production of nitrogen compounds
02/26/2003CN1102146C Synthesis of amidosulfourea containing substituted furan nucleus
02/19/2003EP1284145A1 2-(3,4-Dihydroxyphenyl)ethyl substituted carbonic acid derivatives and their use
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/17/2003CA2398112A1 2-(3,4-dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/11/2003US6518309 Microbiocidal properties of poy-substituted guanidinium salts
02/06/2003WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
02/06/2003WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
02/05/2003EP1280525A2 Methods and compositions for modulating alpha adrenergic receptor activity
02/05/2003EP1280524A2 Methods and compositions for modulating alpha adrenergic receptor activity
02/05/2003EP1280495A2 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
01/2003
01/29/2003EP0973735B1 Polyaromatic antiviral compositions
01/28/2003US6512140 Cyclization, iminoesterification, hydrolysis, in situ oxidation, sulfiding, cleavage, and purification
01/28/2003US6511989 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
01/22/2003EP1277729A1 Ppar (gamma) modulators
01/22/2003CN1392144A 3-amino-2-mercapto phenyl formic acid erivative and its preparation
01/16/2003WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
01/15/2003CN1391473A VLA-4 inhibitor compounds
01/14/2003US6506937 Used as antiarrhythmics
01/09/2003US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives
01/08/2003EP1272459A1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
01/03/2003WO2003000643A1 Nitrate ester derivatives useful for preparing drugs for epilepsy
01/01/2003CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use
12/2002
12/31/2002US6500812 Gastrointestinal disorders; antiinflammatory agents
12/27/2002WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/24/2002US6498265 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
12/19/2002WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/18/2002EP1265852A1 Substituted imide derivatives
12/12/2002WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/11/2002EP0782567B2 Isothiourea derivatives as no synthase inhibitors
12/11/2002EP0752813B1 Inhibitors of metazoan parasite proteases
12/04/2002EP1261329A2 Il-8 receptor antagonists
11/2002
11/28/2002WO2002057273A9 Serine protease inhibitors comprising a hydrogen-bond acceptor
11/28/2002US20020177627 Microbiocidal properties of poly-substituted guanidinium salts
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 32